大行評級丨里昂:料蒙牛受惠原奶價格回穩 升目標價至20.1港元
里昂發表報吿,原奶售價回穩蒙牛(2319.HK)有利,上調目標價至20.1港元。報吿指出,原奶售價有回穩跡象,特別是跌幅正在收窄,加上乳品消費有望好轉,當中屬龍頭之一的A股上市公司伊利(600887.SH),已估計本季及明年盈利有望持續好轉。該行又指,隨着原奶價格回穩,有望帶挈蒙牛非經營成本反彈,一旦回升可延續至明年第三季,將有望為蒙牛淨利潤提升5.5億元人民幣。基於業務最新情況,里昂將蒙牛淨利潤2026年純利提高4%,重申“跑贏行業”評級,目標價從19.4港元調高3.6%至20.1港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.